| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |